SALL4 and lung carcinoma: Furthermore, SALL4 knockdown also inactivated the IGF1R/EGFR downstream intermediate target AKT, as seen from downregulation of phospho-AKT, but not MAPK in the four lung cancer cell lines examined (Figure 3b).